Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoko Yoshida

Showing results (51-60 of 174) with videos related to

Pageof 18
Sort By:
British Journal of Haematology|December 28, 2019
The role of anti-complement factor H antibodies in the development of atypical haemolytic uremic syndrome: a possible contribution to abnormality of platelet functionMadoka Fujisawa, Atsushi Yasumoto, Hideki Kato, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 2, 2023
Effects of Custom-Designed Soft Contact Lenses on Irregular Astigmatism Correction in Patients with KeratoconusTomoya Nishida, Takashi Kojima, Saaya Ogi, et al.
The Journal of Investigative Dermatology|June 13, 2002
Molecular architecture of tight junctions of periderm differs from that of the maculae occludentes of epidermisKazumasa Morita, Mikio Furuse, Yoko Yoshida, et al.
Oncogene|June 29, 2004
Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1)Akiyoshi Komuro, Takeshi Imamura, Masao Saitoh, et al.
Brain & Development|February 4, 2018
Efficacy and safety of everolimus in patients younger than 12 months with congenital subependymal giant cell astrocytomaIchiro Kuki, Hisashi Kawawaki, Shin Okazaki, et al.
CEN Case Reports|June 10, 2019
Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coliShinya Nakayama, Shuma Hirashio, Haruka Yorishima, et al.
Journal of Diabetes Research|August 2, 2021
Characteristics Associated with Early Worsening of Retinopathy in Patients with Type 2 Diabetes Diagnosed with Retinopathy at Their First Visit: A Retrospective Observational StudySayaka Wakabayashi Sugawa, Yoko Yoshida, Yusuke Hikima, et al.
International Journal of Hematology|May 20, 2016
No association between dysplasminogenemia with p.Ala620Thr mutation and atypical hemolytic uremic syndromeToshiyuki Miyata, Yumiko Uchida, Yoko Yoshida, et al.
Clinical and Experimental Nephrology|February 19, 2011
Risk of macrovascular disease stratified by stage of chronic kidney disease in type 2 diabetic patients: critical level of the estimated glomerular filtration rate and the significance of hyperuricemiaKentaro Tanaka, Shigeko Hara, Akifumi Kushiyama, et al.
Biological & Pharmaceutical Bulletin|November 3, 2009
Identification of candidate genes determining chemosensitivity to anti-cancer drugs of gastric cancer cell linesTomoki Nakamura, Noriyuki Nakatsu, Yoko Yoshida, et al.
Pageof 18

Showing results (51-60 of 174) with videos related to

Sort By:
Pageof 18
British Journal of Haematology|December 28, 2019
The role of anti-complement factor H antibodies in the development of atypical haemolytic uremic syndrome: a possible contribution to abnormality of platelet functionMadoka Fujisawa, Atsushi Yasumoto, Hideki Kato, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 2, 2023
Effects of Custom-Designed Soft Contact Lenses on Irregular Astigmatism Correction in Patients with KeratoconusTomoya Nishida, Takashi Kojima, Saaya Ogi, et al.
The Journal of Investigative Dermatology|June 13, 2002
Molecular architecture of tight junctions of periderm differs from that of the maculae occludentes of epidermisKazumasa Morita, Mikio Furuse, Yoko Yoshida, et al.
Oncogene|June 29, 2004
Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1)Akiyoshi Komuro, Takeshi Imamura, Masao Saitoh, et al.
Brain & Development|February 4, 2018
Efficacy and safety of everolimus in patients younger than 12 months with congenital subependymal giant cell astrocytomaIchiro Kuki, Hisashi Kawawaki, Shin Okazaki, et al.
CEN Case Reports|June 10, 2019
Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coliShinya Nakayama, Shuma Hirashio, Haruka Yorishima, et al.
Journal of Diabetes Research|August 2, 2021
Characteristics Associated with Early Worsening of Retinopathy in Patients with Type 2 Diabetes Diagnosed with Retinopathy at Their First Visit: A Retrospective Observational StudySayaka Wakabayashi Sugawa, Yoko Yoshida, Yusuke Hikima, et al.
International Journal of Hematology|May 20, 2016
No association between dysplasminogenemia with p.Ala620Thr mutation and atypical hemolytic uremic syndromeToshiyuki Miyata, Yumiko Uchida, Yoko Yoshida, et al.
Clinical and Experimental Nephrology|February 19, 2011
Risk of macrovascular disease stratified by stage of chronic kidney disease in type 2 diabetic patients: critical level of the estimated glomerular filtration rate and the significance of hyperuricemiaKentaro Tanaka, Shigeko Hara, Akifumi Kushiyama, et al.
Biological & Pharmaceutical Bulletin|November 3, 2009
Identification of candidate genes determining chemosensitivity to anti-cancer drugs of gastric cancer cell linesTomoki Nakamura, Noriyuki Nakatsu, Yoko Yoshida, et al.
Pageof 18